NEPHROS, INC. Restricted Stock or Unit Expense
NEPHROS, INC. (NEPH) reported Restricted Stock or Unit Expense of $252.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2020-02-27
- NEPHROS, INC. restricted stock or unit expense for the quarter ending 2016-12-31 was $253.00K.
- NEPHROS, INC. restricted stock or unit expense for the quarter ending 2016-09-30 was $0.00.
- NEPHROS, INC. restricted stock or unit expense for the quarter ending 2016-06-30 was $14.00K.
- NEPHROS, INC. restricted stock or unit expense for the quarter ending 2016-03-31 was $25.00K.
- NEPHROS, INC. restricted stock or unit expense for fiscal 2019 was $252.00K, a 33.16% decline from fiscal 2018.
- NEPHROS, INC. restricted stock or unit expense for fiscal 2018 was $377.00K, a 9.28% increase from fiscal 2017.
- NEPHROS, INC. restricted stock or unit expense for fiscal 2017 was $345.00K, a 18.56% increase from fiscal 2016.
- NEPHROS, INC. restricted stock or unit expense for fiscal 2016 was $291.00K, a 60.77% increase from fiscal 2015.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month | Restricted Stock or Unit Expense 9 month | Restricted Stock or Unit Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $252.00K 10-K · filed 2020-02-27 | |||
| 2018-12-31 | $377.00K 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $345.00K 10-K · filed 2019-03-12 | |||
| 2016-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $253.00K derived: sum of 2 quarters · filed 2018-02-26 | $267.00K derived: sum of 3 quarters · filed 2018-02-26 | $291.00K 10-K · filed 2018-02-26 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $14.00K derived: sum of 2 quarters · filed 2016-11-10 | $38.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $14.00K 10-Q · filed 2016-08-08 | $38.00K 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | $25.00K 10-Q · filed 2016-05-11 | |||
| 2015-12-31 | $181.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |